FEDERATED HERMES, INC. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 92 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$243,254
-35.6%
9,053
-14.6%
0.00%0.0%
Q2 2023$377,853
+55.9%
10,596
+11.1%
0.00%0.0%
Q1 2023$242,341
-48.8%
9,541
-18.2%
0.00%0.0%
Q4 2022$473,295
-20.6%
11,669
-35.3%
0.00%
-50.0%
Q3 2022$596,000
+25.5%
18,043
+34.0%
0.00%
+100.0%
Q2 2022$475,000
-54.9%
13,468
-41.2%
0.00%
-50.0%
Q1 2022$1,053,000
-17.3%
22,906
+19.2%
0.00%0.0%
Q4 2021$1,274,000
-9.6%
19,217
-14.9%
0.00%
-33.3%
Q3 2021$1,410,000
-78.0%
22,590
-70.8%
0.00%
-75.0%
Q2 2021$6,406,000
+27.9%
77,347
+2.4%
0.01%
+20.0%
Q1 2021$5,009,000
+22.0%
75,528
+41.1%
0.01%
+25.0%
Q4 2020$4,106,000
+414.5%
53,510
+188.6%
0.01%
+300.0%
Q3 2020$798,000
-47.3%
18,539
-47.1%
0.00%
-50.0%
Q2 2020$1,513,000
-73.0%
35,030
-82.0%
0.00%
-75.0%
Q1 2020$5,602,000
-71.2%
194,708
-36.5%
0.02%
-62.8%
Q4 2019$19,446,000
+510.5%
306,575
+171.3%
0.04%
+437.5%
Q3 2019$3,185,000
-6.2%
113,023
-11.8%
0.01%0.0%
Q2 2019$3,397,000
+17778.9%
128,212
+12052.8%
0.01%
Q1 2019$19,000
+137.5%
1,055
+52.0%
0.00%
Q4 2018$8,000
-99.6%
694
-99.4%
0.00%
-100.0%
Q3 2018$2,247,000
+486.7%
117,200
+316.4%
0.01%
+400.0%
Q2 2018$383,000
+5371.4%
28,145
+2897.3%
0.00%
Q1 2018$7,000
+250.0%
939
-23.7%
0.00%
Q4 2016$2,000
-66.7%
1,231
+59.2%
0.00%
Q3 2016$6,0007730.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2018
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders